moxifloxacin has been researched along with Bacterial Infections, Gram-Negative in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.71) | 18.2507 |
2000's | 18 (51.43) | 29.6817 |
2010's | 13 (37.14) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
Authors | Studies |
---|---|
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Hiramatsu, K; Kikuchi, K; Ohtsuka, M; Ono, Y; Sasaki, T; Shimizu, K; Takahashi, N | 1 |
Asai, K; Imoto, W; Kakeya, H; Kaneko, Y; Kawaguchi, T; Kuwabara, G; Nakaie, K; Niki, M; Oshima, K; Shibata, W; Watanabe, T; Yamada, K; Yamairi, K | 1 |
Chodosh, J; Ma, KK; Saeed, HN; Tone, SO | 1 |
Albaayit, SFA; Ghafil, JA; Hafiz, MH; Radhi, SN; Radif, HM; Zgair, AK | 1 |
Drewelow, B; Hopt, UT; Keck, T; Klock, A; Kloft, C; Mundkowski, RG; Wellner, UF; Wicha, SG; Wittel, UA | 1 |
Giamarellos-Bourboulis, EJ; Ioannidis, O; Koutelidakis, I; Papaziogas, B; Paraskevas, G; Tsiaousis, P | 1 |
Eguchi, H; Hotta, F; Kusujima, K; Kuwahara, T; Mitamura, Y; Naito, T | 1 |
Cai, X; Cui, J; Ni, W; Wei, C | 1 |
Chong, SY; Chong, Y; Chung, HS; Hong, SG; Lee, K; Suh, Y | 1 |
Chhabra, MS; Mortensen, JE; Motley, WW | 1 |
Basile, V; Capone, D; Carrano, R; Federico, S; Kadilli, I; Nappi, R; Polichetti, G; Sabbatini, M; Tarantino, G | 1 |
Giamarellos-Bourboulis, EJ; Gougoudi, E; Korakianitis, I; Mirtsou, V; Raftogiannis, M | 1 |
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
Kim, HJ; Seo, JW; Son, SW | 1 |
Ahmed, AA; Pineda, R | 1 |
Burd, EM; Sharp, SE | 1 |
Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
Chiang, SR; Chuang, YC; Ko, WC; Lee, HC; Tang, HJ; Wang, YY | 1 |
Andremont, A; Cavallo, P; Chardon, H; Courvalin, P; Dabernat, H; Drugeon, H; Etienne, J; Goldstein, F; Leclercq, R; Nguyen, J; Rio, Y; Soussy, CJ | 1 |
Hoepelman, I | 1 |
Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J | 1 |
McAllum, P; Poutanen, SM; Slomovic, AR; Srinivasan, S | 1 |
Eremina, LV; Iakovlev, SV; Nazarov, VV; Ramishvili, VSh | 1 |
Marchese, A; Roveta, S; Schito, AM; Schito, GC | 1 |
Allewelt, M; Lode, H; Lorenz, J; Ott, SR; Reimnitz, P | 1 |
Bilgen, FS; Kut, MS; Palaz, FK; Sanioğlu, S; Sokullu, O; Yavuz, SS | 1 |
Lindsell, C; Ryan, RJ; Sheehan, P | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Chartrand, SA; Moland, ES; Pong, A; Sanders, CC; Thomson, KS | 1 |
Bjarnason, J; Blondeau, JM; Laskowski, R; Stewart, C | 1 |
Friedrich, A; Martino, P; Micozzi, A; Monaco, M; Tarasi, A; Venditti, M | 1 |
Iakovlev, SV; Iakovlev, VP; Polushkina, NR | 1 |
3 review(s) available for moxifloxacin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Alcaligenes xylosoxidans contact lens-related keratitis--a case report and literature review.
Topics: Adult; Alcaligenes; Anti-Bacterial Agents; Aza Compounds; Conjunctiva; Contact Lenses; Cornea; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Keratitis; Male; Moxifloxacin; Quinolines | 2011 |
[New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Pneumonia; Quinolines; Respiratory Tract Infections | 2004 |
[Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
Topics: Anti-Infective Agents; Aza Compounds; Clinical Trials as Topic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Moxifloxacin; Quinolines; Respiratory Tract Infections | 2001 |
5 trial(s) available for moxifloxacin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Is Moxifloxacin a Treatment Option for Pancreatic Infections? A Pharmacometric Analysis of Serum and Pancreatic Juice.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Moxifloxacin; Pancreas; Pancreatic Juice; Prospective Studies | 2019 |
Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Cyclosporine; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Moxifloxacin; Quinolines; Tacrolimus; Time Factors; Urinary Tract Infections | 2010 |
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome | 2006 |
[Efficacy of moxifloxacin in the treatment of secondary peritonitis].
Topics: Adult; Aged; Anti-Infective Agents; APACHE; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Quinolines; Treatment Outcome | 2006 |
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Moxifloxacin; Pneumonia, Aspiration; Quinolines; Radiography; Sulbactam | 2008 |
27 other study(ies) available for moxifloxacin and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia.
Topics: Alleles; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chromosomes, Bacterial; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Molecular Sequence Data; Sequence Homology, Amino Acid; Stenotrophomonas maltophilia | 2008 |
A mouse model of rapidly progressive fatal haemorrhagic pneumonia caused by Stenotrophomonas maltophilia.
Topics: Animals; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Mice; Moxifloxacin; Pneumonia; Stenotrophomonas maltophilia | 2020 |
Ochrobactrum anthropi Keratitis in a Boston Type 1 Keratoprosthesis Recipient.
Topics: Aged; Anti-Bacterial Agents; Artificial Organs; Ceftazidime; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Moxifloxacin; Ochrobactrum anthropi; Prostheses and Implants; Slit Lamp Microscopy; Visual Acuity | 2021 |
Moxifloxacin reduces Stenotrophomonas maltophilia adhesion to mouse intestinal tract in vitro.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Disease Models, Animal; Gram-Negative Bacterial Infections; Intestines; Kinetics; Male; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Stenotrophomonas maltophilia | 2017 |
Effect of moxifloxacin on survival, lipid peroxidation and inflammation in immunosuppressed rats with soft tissue infection caused by Stenotrophomonas maltophilia.
Topics: Animals; Anti-Bacterial Agents; Fluoroquinolones; Gram-Negative Bacterial Infections; Immunocompromised Host; Leukocyte Count; Lipid Peroxidation; Male; Moxifloxacin; Rats; Soft Tissue Infections; Stenotrophomonas maltophilia | 2014 |
Achromobacter buckle infection diagnosed by a 16S rDNA clone library analysis: a case report.
Topics: Achromobacter; Anti-Bacterial Agents; Betamethasone; Cefdinir; Cephalosporins; Device Removal; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Gram-Negative Bacterial Infections; Humans; Middle Aged; Moxifloxacin; Polymerase Chain Reaction; Prosthesis-Related Infections; Retinal Detachment; RNA, Ribosomal, 16S; Scleral Buckling | 2014 |
A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Minocycline; Monte Carlo Method; Moxifloxacin; Pneumonia; Sputum; Stenotrophomonas maltophilia; Tigecycline | 2015 |
Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftazidime; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Stenotrophomonas maltophilia; Ticarcillin; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Eikenella corrodens as a causative agent for neonatal conjunctivitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clavulanic Acid; Conjunctivitis; Drug Administration Schedule; Drug Therapy, Combination; Eikenella corrodens; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infant; Moxifloxacin; Ophthalmic Solutions; Quinolines; Treatment Outcome | 2008 |
Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Greece; Hospitalization; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Stenotrophomonas maltophilia; Time Factors | 2010 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
A case of Stenotrophomonas maltophilia keratitis effectively treated with moxifloxacin.
Topics: Aged; Anti-Infective Agents; Aza Compounds; Cornea; Diagnosis, Differential; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Keratitis; Male; Moxifloxacin; Ophthalmic Solutions; Quinolines; Stenotrophomonas maltophilia; Visual Acuity | 2011 |
Photo quiz: A 36-year-old with recurrent conjunctivitis.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Aza Compounds; Bacterial Typing Techniques; Bacteriological Techniques; Ciprofloxacin; Conjunctivitis; Corneal Transplantation; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Microscopy; Moxifloxacin; Paracoccus; Quinolines; Recurrence; Surgical Wound Infection | 2012 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 2003 |
In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.
Topics: Anti-Infective Agents; Aza Compounds; Cross Infection; Fluoroquinolones; France; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines | 2003 |
In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.
Topics: Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Stomach Diseases | 2006 |
Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty.
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Piperacillin; Quinolines | 2006 |
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis.
Topics: Anti-Bacterial Agents; Aza Compounds; Biofilms; Biomass; Bronchitis, Chronic; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Spectrophotometry | 2007 |
Stenotrophomonas maltophilia endocarditis treated with moxifloxacin-ceftazidime combination and annular wrapping technique.
Topics: Adult; Anti-Bacterial Agents; Aortic Valve; Aza Compounds; Ceftazidime; Drug Therapy, Combination; Endocarditis, Bacterial; Equipment Design; Fluoroquinolones; Gram-Negative Bacterial Infections; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Moxifloxacin; Quinolines; Stenotrophomonas maltophilia | 2008 |
Fluoroquinolone resistance during 2000-2005: an observational study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Utilization; Enterobacter aerogenes; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Pharmacy Service, Hospital; Pneumonia, Bacterial; Quinolines | 2008 |
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 1999 |
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Quinolines; Staphylococcus aureus; Streptococcus pneumoniae | 1999 |
Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms.
Topics: Anti-Infective Agents; Aza Compounds; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines | 2000 |
In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Blood; Fluoroquinolones; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Stenotrophomonas maltophilia | 2001 |